The Arg753Gln Polymorphism of Toll-Like Receptor 2 Has a Lower Occurrence in Patients with Syphilis, Suggesting Its

Linda Grillová1, Jana Musilová1, Klára Janečková1

  • 1Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Infection and Immunity
|October 20, 2020
PubMed

Insights

A specific gene variant, Toll-like receptor 2 (TLR2) Arg753Gln, was found less frequently in syphilis patients. This suggests the TLR2 Arg753Gln polymorphism may offer protection against developing syphilis.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Syphilis, caused by *Treponema pallidum* subsp. *pallidum*, triggers proinflammatory cytokines via bacterial lipoproteins interacting with Toll-like receptor 2 (TLR2).
  • Nonsynonymous single-nucleotide polymorphisms in TLR2 can affect signaling pathways, potentially influencing susceptibility to infections like syphilis.

Purpose of the Study:

  • To investigate the association between the TLR2 Arg753Gln polymorphism and susceptibility to syphilis.

Main Methods:

  • A case-control study was conducted involving 137 syphilis patients and 221 healthy controls.
  • The frequency of the Arg753Gln polymorphism (2258G→A; rs5743708) in the TLR2 gene was determined in both groups.

Main Results:

  • The Arg753Gln variant was found at a significantly lower frequency in syphilis patients (3%) compared to controls (10.9%).

Conclusions:

  • The TLR2 Arg753Gln polymorphism may confer a protective effect against the development of syphilis, potentially due to reduced TLR2 signaling.